SLU-PP-332: What Is It? Mechanism Explained

SLU-PP-332 is a synthetic small molecule that acts as an agonist at the estrogen-related receptors (ERRs), a family of nuclear receptors that regulate gene transcription. It has no amino-acid chain, although suppliers often list it alongside peptides, and it is sold in Australia for in-vitro laboratory use only.

How does SLU-PP-332 work?

SLU-PP-332 is described as a pan-ERR agonist, meaning it activates ERRα, ERRβ and ERRγ, with the greatest reported activity at ERRα. The name points to Saint Louis University, where the compound was developed.

ERRs are classed as orphan receptors. In the literature they are linked to genes involved in mitochondrial function and oxidative metabolism, which makes ERRα a recurring target in cell-based assays.

What should a SLU-PP-332 COA show?

A batch COA should show analytical data for identity and purity, with the method named for each. Because this is a small molecule, laboratories typically rely on HPLC and mass spectrometry.

Our guides to HPLC purity and reading a certificate of analysis explain each line. Laboratory material is typically stored sealed and protected from light and moisture, following the supplier's specification.

Research use only

SLU-PP-332 5mg is supplied strictly for in-vitro laboratory and research use. It is not approved by the TGA for therapeutic use and is not for human or animal consumption. See Are Research Peptides Legal to Buy in Australia? for the regulatory position.